1. Medtech Insight
  2. >>Policy & Regulation
  3. >>Regulation

Blockchain: The Answer to Medtech Traceability?

Pressures to control supply chains are increasing while governments are adding new requirements for companies to better track individual products. Blockchain technology is most often associated with cryptocurrencies like Bitcoin, but it has a lot to offer to the medtech space as a tool to enhance product traceability and address new EU regulatory requirements. Lydia Torne, with law firm Simmons & Simmons LLP, explores the prospects.

Blockchain (whiteMocca/Shutterstock.com)
About The Author

Lydia Torne is a Managing Associate at the international law firm Simmons & Simmons LLP. She specializes in all types of transactions involving intellectual property, with a particular focus on the life sciences sector. She also advises on life sciences regulatory compliance issues including product classification, interactions with health-care professionals, clinical trials, market access, supply chain requirements, marketing and pharmacovigilance.

Having revolutionized the financial markets sector with the creation of cryptocurrencies such as Bitcoin, other sectors are now exploring whether blockchain technology could transform their own industries. The life sciences...

Pressures to control supply chains are increasing while governments are adding new requirements for companies to better track individual products. This article explores how blockchain technology could help address these...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

Plans For Specific EU Orphan And Pediatric Device Expert Panel Need To Go Further

 
• By Amanda Maxwell

Moves are at last underway for a more specific focus on orphan and pediatric devices. They are a start; but experts are calling for more to support this sector.

MORE Details On MHRA’s Online Platform For Post Market Surveillance

 
• By Ashley Yeo

Post-market surveillance regulations for medtech system users in Great Britain coming into force on 16 June will make new data requirements under new compliance deadlines.

‘Help Us Deregulate’: RFK Announces RFI For Trimming Government Health Agencies

 
• By Brian Bossetta

HHS Secretary Robert F. Kennedy, Jr. is asking the public to help cut waste across the government’s health agencies. Kennedy announced a 60-day comment period allowing the public to take part in a broader federal initiative to reduce regulations and increase transparency.

MedTech Europe’s Bisazza Urges Action As US Tariffs Jeopardize Critical Global Supply Chains

 
• By Amanda Maxwell

The intricate assembly of medical devices, often involving over 1,000 globally sourced components, faces severe disruption due to new US tariffs. These barriers could halt production and devastate small and medium-sized enterprises (SMEs), MedTech Europe’s CEO, Oliver Bisazza, warns in an interview with Medtech Insight.

More from Policy & Regulation